case_images: PMC6666367_01
case_images: Response of a metastatic adenocarcinoma patient to dabrafenib and trametinib. The red arrows indicate the reduced mass.
case_images: OTT-12-6045-g0005.jpg
case_images: PMC6666367_01_OTT-12-6045-g0005.jpg
case_images: F0005
case_images: However, subsequent treatment with dabrafenib and trametinib after three previous lines of chemotherapy resulted in regression of the tumor after one month (Figure 5).